Intersection of minority health, health disparities, and social determinants of health with psychopharmacology and substance use.
Exp Clin Psychopharmacol
; 29(5): 427-428, 2021 Oct.
Article
en En
| MEDLINE
| ID: mdl-34636584
These articles provide a window into the breadth of issues at the intersection of MHDS with psychopharmacology and substance use. Integrating the fields of psychopharmacology and basic behavioral addictions science with research on MHDS is not only of public health importance, but can help further elucidate our understanding of human behavior in all of its complexity. As demonstrated here, a better understanding of the synergy between societal context(s) and individual-level processes can lead to interventions tailored to specific risk and resilience factors; interventions that are personalized and contextualized have the potential to improve the health of our society. We are very grateful to the authors for their contributions to this special issue. We hope that professionals from various disciplines who read this special issue become inspired to bridge psychopharmacological and social determinants perspectives in their own work, and, in turn, accelerate scientific progress within each field. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Psicofarmacología
/
Conducta Adictiva
/
Trastornos Relacionados con Sustancias
Aspecto:
Determinantes_sociais_saude
Límite:
Humans
Idioma:
En
Revista:
Exp Clin Psychopharmacol
Asunto de la revista:
PSICOFARMACOLOGIA
Año:
2021
Tipo del documento:
Article
Pais de publicación:
Estados Unidos